S. Samuel Weigt

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 559 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Colonization With Small Conidia Aspergillus Species Is Associated With Bronchiolitis Obliterans Syndrome: A Two-Center Validation Study

S. Samuel Weigt, CA Finlen Copeland, Ariss Derhovanessian et al. · American Journal of Transplantation · 2013 · 113 citations · Full text

Life Sciences, Immunology, Microbiology +14

Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortality

Hsuanwen C. Huang, S. Samuel Weigt, Ariss Derhovanessian et al. · The Journal of Heart and Lung Transplantation · 2011 · 96 citations · Full text

Medicine, Infectious Diseases, Microbiology +16

Graft Loss and CLAD-Onset Is Hastened by Viral Pneumonia After Lung Transplantation

Paul R Allyn, Erin Duffy, Romney M. Humphries et al. · Transplantation · 2016 · 85 citations · Full text

Medicine, Infectious Diseases, Microbiology +17

CXCR3 Ligands Are Associated with the Continuum of Diffuse Alveolar Damage to Chronic Lung Allograft Dysfunction

Michael Y. Shino, S. Samuel Weigt, Ning Li et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 61 citations · Full text

Medicine, Immunology, Pathology +17